Sexual Well-being of Women Undergoing Mastectomy and Reconstruction

NCT ID: NCT07234461

Last Updated: 2026-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-21

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study plans to collect data from patients on sexual well-being after mastectomy and immediate reconstruction by surveys.

This data can support preoperative patient counselling and the prevention and care of adverse effects of cancer treatments.

Specific subpopulations of mastectomy women showing severe sexual impairment can be outlined; they may benefit from lifestyle changes and intervention strategies (intravaginal use of diazepam, local hyaluronic acid, intravaginal use of spermidine, pelvic floor gymnastic and physiotherapy).

Our goal is to improve quality of life of breast cancer patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mastectomy and Breast Reconstruction Sexual Wellness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Survey

At 1-year follow-up, breast cancer patients who underwent mastectomy and reconstruction are asked to complete several questionnaires after the medical consultation collecting sociodemographic information and their sexual well-being.

Group Type EXPERIMENTAL

Survey using a questionnaire.

Intervention Type OTHER

Questionnaires collecting sociodemographic information and their sexual well-being.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Survey using a questionnaire.

Questionnaires collecting sociodemographic information and their sexual well-being.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing mastectomy for primary breast cancer;
* High-risk healthy patients undergoing risk reducing mastectomies;
* Unilateral and/or bilateral mastectomies;
* If unilateral mastectomy, both patients requiring or not contralateral mammaplasty of the healthy breast;
* All reconstructive procedures included (autologous and heterologous reconstructions).

Exclusion Criteria

* Patients undergoing breast conservation;
* Patients who previously underwent breast cancer treatment, requiring further surgery for local relapse or secondary breast cancers;
* Delayed post-mastectomy reconstructions;
* Patients not available for e-correspondence.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European Institute of Oncology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Azienda Ospedaliero Universitaria Consorziale Policlinico

Bari, Italy, Italy

Site Status NOT_YET_RECRUITING

Istituto Tumori Giovanni Paolo II

Bari, Italy, Italy

Site Status NOT_YET_RECRUITING

Policlinico Sant'Orsola-Malpighi

Bologna, Italy, Italy

Site Status NOT_YET_RECRUITING

Ospedale Bufalini di Cesena

Cesena, Italy, Italy

Site Status NOT_YET_RECRUITING

Presidio Ospedaliero GB Morgagni-Pierantoni

Forlì, Italy, Italy

Site Status NOT_YET_RECRUITING

European Institute of Oncology

Milan, Italy, Italy

Site Status RECRUITING

Ospedale Mater Olbia

Olbia, Italy, Italy

Site Status NOT_YET_RECRUITING

Azienda Ospedale Università di Padova

Padua, Italy, Italy

Site Status NOT_YET_RECRUITING

Policlinico Paolo Giaccone

Palermo, Italy, Italy

Site Status NOT_YET_RECRUITING

Policlinico San Matteo

Pavia, Italy, Italy

Site Status NOT_YET_RECRUITING

Azienda Ospedaliero Universitaria Pisana

Pisa, Italy, Italy

Site Status NOT_YET_RECRUITING

Campus Biomedico

Roma, Italy, Italy

Site Status NOT_YET_RECRUITING

Istituto Tumori Regina Elena

Roma, Italy, Italy

Site Status NOT_YET_RECRUITING

Policlinico Gemelli

Roma, Italy, Italy

Site Status NOT_YET_RECRUITING

A.O.U. Città della salute e della scienza di Torino

Torino, Italy, Italy

Site Status NOT_YET_RECRUITING

Azienda Ospedaliera di Treviso

Treviso, Italy, Italy

Site Status NOT_YET_RECRUITING

Ospedale di Cattinara

Trieste, Italy, Italy

Site Status NOT_YET_RECRUITING

Ospedale Universitario di Udine

Udine, Italy, Italy

Site Status NOT_YET_RECRUITING

Breast Unit Settelaghi

Varese, Italy, Italy

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Francesca De Lorenzi, MD

Role: CONTACT

+39 0257489.394

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Angela Gurrado, MD

Role: primary

+39 080 919 8749

Daniela Anna Cutrignelli, MD

Role: primary

+39 0805555917

Chiara Gelati, MD

Role: primary

+39 051 2143614

Rossella Sgarzani, MD

Role: primary

+39 0547 352111

Annalisa Curcio, MD

Role: primary

+39 0543731676

Francesca De Lorenzi, MD

Role: primary

+39 0257489.394

Sonia Bove, MD

Role: primary

+39 0789 18999

Laura Pandis, MD

Role: primary

+39 0498212768

Adriana Cordova, MD

Role: primary

+39 091 655 34 00

Adele Sgarella, MD

Role: primary

+39 0382502288

Manuela Roncella, MD

Role: primary

+39 050992729

Barbara Cagli, MD

Role: primary

+39 06 9762 0968

Lucia Mangialardi, MD

Role: primary

+39 351 319 1190

Marzia Salgarello, MD

Role: primary

+39 06 3015.4667

Maria Alessandra Bocchiotti, MD

Role: primary

+39 0116336991

Elisa Antoniazzi, MD

Role: primary

+39 0422 322372

Nadia Renzi, MD

Role: primary

+39 040 3994258

Glenda Caputo, MD

Role: primary

+39 0432 559432

Francesca Rovera, MD

Role: primary

+39 0332 278111

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

L2-367

Identifier Type: OTHER

Identifier Source: secondary_id

UID 4897

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Living Well After Breast Surgery
NCT03834532 COMPLETED NA